Related Experiment Video
Updated: Jan 28, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction
Josefin Mörtberg1, Kristina Lundwall2, Fariborz Mobarrez3
1Division of Nephrology, Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden. josefin.mortberg@sll.se.
Background:
Patients with chronic kidney disease (CKD) have a high risk of recurring thrombotic events following acute myocardial infarction (AMI). Microparticles (MPs) are circulating small vesicles shed from various cells. Platelet microparticles (PMPs) reflect platelet activation and endothelial microparticles (EMPs) reflect endothelial activation or dysfunction. Both increase following AMI, and may mediate important biological effects. We hypothesized that AMI patients with CKD have further elevated PMPs and EMPs compared with non-CKD patients, despite concurrent antithrombotic treatment.
Methods:
We performed a descriptive study of patients with AMI. Fasting blood samples were acquired from 47 patients on dual antiplatelet treatment. Patients were stratified by renal function: normal (H; n = 19) mean eGFR 88; moderate CKD (CKD3; n = 15) mean eGFR 47, and severe CKD (CKD4-5; n = 13) mean eGFR 20 mL/min/1.73 m2. MPs were measured by flow-cytometry and phenotyped according to size (< 1.0 μm) and expression of CD41 (GPIIb; PMPs) and CD62E (E-selectin; EMPs). In addition, expression of platelet activation markers P-selectin (CD62P) and CD40ligand (CD154) were also investigated.
Results:
PMPs expressing CD40 ligand were higher in CKD4-5: 210 /μl (174-237); median and interquartile range; vs. group H; 101 /μl (71-134; p < 0.0001) and CKD 3: 142 /μl (125-187; p = 0.006). PMPs expressing P-selectin were higher in CKD4-5 compared with H, but not in CKD3. EMPs were higher in CKD4-5; 245 /μl (189-308) compared with H; 83 /μl (53-140; p < 0.0001) and CKD3; 197 /μl (120-245; p < 0.002).
Conclusions:
In AMI patients, PMPs and EMPs from activated platelets and endothelial cell are further elevated in CKD patients. This indicate impaired endothelial function and higher platelet activation in CKD patients, despite concurrent antiplatelet treatment.
Insights
Patients with chronic kidney disease (CKD) and acute myocardial infarction (AMI) show elevated platelet-rich microparticles (PMPs) and endothelial microparticles (EMPs). These findings suggest increased platelet activation and endothelial dysfunction in CKD patients, even with antiplatelet therapy.
Area of Science:
- Cardiovascular Research
- Nephrology
- Hematology
Background:
- Patients with chronic kidney disease (CKD) face a heightened risk of recurrent thrombotic events post-acute myocardial infarction (AMI).
- Microparticles (MPs), including platelet-derived (PMPs) and endothelial-derived (EMPs), are biomarkers of cellular activation and dysfunction.
- Elevated MPs are observed after AMI, potentially mediating biological effects.
Purpose of the Study:
- To investigate whether AMI patients with CKD exhibit higher levels of PMPs and EMPs compared to non-CKD patients.
- To assess the impact of CKD severity on PMP and EMP levels in AMI patients undergoing antithrombotic treatment.
Main Methods:
- A descriptive study involving 47 AMI patients stratified by renal function: normal (H), moderate CKD (CKD3), and severe CKD (CKD4-5).
- Blood samples were analyzed using flow cytometry to quantify PMPs (CD41+) and EMPs (CD62E+).
- Expression of platelet activation markers (CD62P, CD40 ligand) on PMPs was also assessed.
Main Results:
- Severe CKD (CKD4-5) patients had significantly higher PMPs expressing CD40 ligand compared to normal (H) and moderate CKD (CKD3) groups (p < 0.0001).
- PMPs expressing P-selectin were elevated in severe CKD (CKD4-5) versus normal (H) but not moderate CKD (CKD3).
- EMPs were significantly higher in severe CKD (CKD4-5) compared to both normal (H) (p < 0.0001) and moderate CKD (CKD3) (p < 0.002) groups.
Conclusions:
- AMI patients with CKD demonstrate further elevation of PMPs and EMPs, indicating heightened platelet activation and endothelial dysfunction.
- These findings persist despite concurrent antiplatelet therapy, highlighting the prothrombotic state associated with CKD in AMI patients.
Related Concept Videos
Serum Studies: Renal Function Tests
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Derivatives of the Trigonometric Functions
Derivatives of Logarithmic Functions
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Derivatives of Simple Functions

